Candidate molecules as diagnostic biomarker for human uterine mesenchymal tumors

• Main Authors: Hayashi T (Author), Sano K (Author), Ichimura T (Author), Gur G (Author), Yaish P (Author), Zharhary D (Author), Kanai Y (Author), Tonegawa S (Author), Yaegashi N (Author), Konishi I (Author)
• Format: Book
• Published: Annals of Cytology and Pathology - Peertechz Publications, 2020-05-14.
• Subjects: Review Article
• Online Access: Connect to this object online.

<p>Unfortunately, uterine leiomyosarcoma still has a poor prognosis. The National Cancer Institute reported that the median overall survival (mOS) at stage I to stage IV of leiomyosarcoma was 31 months. Norwegian reports show that mOS of uterine leiomyosarcoma is as poor as eight years at stag...